Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.72 BRL | -0.56% | -.--% | -10.95% |
Jun. 20 | Needham Adjusts Price Target on Jazz Pharmaceuticals to $210 From $222, Maintains Buy Rating | MT |
Jun. 20 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- JAZZ Stock
- J2AZ34 Stock
- Revisions Jazz Pharmaceuticals plc